ODIWIN INJECTION
MRP: 134
Packaging: 10x2ML
Pack Type: injection
Composition:
Ondansetron 2mg
Indication:
Chemotherapy Induced Nausea & Vomiting (CINV), Radiotherapy Induced Nausea & Vomiting (RINV), Post Operative Nausea & Vomiting (PONV).
Description:
Ondansetron 2 mg/ml Injection is a selective 5-HT3 receptor antagonist that prevents nausea and vomiting caused by:
Chemotherapy (CINV)
Radiotherapy (RINV)
Post-operative recovery (PONV)
It works by blocking serotonin receptors in the brain and gastrointestinal tract, which are responsible for triggering vomiting. Ondansetron provides rapid relief and is often used in hospitals prior to and after procedures that carry a high emetic risk.
This dosage is typically provided in 2 ml ampoules (4 mg total dose), for intravenous (IV) or intramuscular (IM) use.
Tags:
- Fast-acting relief from nausea and vomiting
- Effective for chemotherapy, radiotherapy, and surgical procedures
- Can be used pre-emptively before emetic events
- Suitable for hospital and emergency settings
- Well-tolerated and safe in most patients
Usage Information
Dosage
Route: Intravenous (IV) or Intramuscular (IM) Usual Adult Dose: 4 mg (2 ml) every 8 hours as needed Pediatric Use: Dose adjusted by body weight Should be administered by a healthcare provider Do not mix with other medications in the same syringe unless compatible
Side Effects
Headache Constipation Fatigue or dizziness Injection site reactions Rare: QT prolongation (in high doses or predisposed patients)
Contraindications
Known hypersensitivity to ondansetron or other 5-HT3 antagonists Congenital long QT syndrome Severe hepatic impairment (use with caution) Concomitant use with apomorphine (due to severe hypotension risk)
Availability
Ondansetron 2mg injection Anti-nausea injection Post-chemotherapy vomiting treatment Ondansetron for surgery nausea 5-HT3 antagonist injection Ondansetron IV for vomiting